Bendong Chen
Yinchuan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Aspartame drives the continuous progression from MASLD to HCC.
Journal: Discover oncology
Published: March 19, 2026
The Prognostic and Biological Value of PGF-Based H&E Pathomics in Hepatocellular Carcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 23, 2025
Study on the Mechanism of CCN2 Promoting Sorafenib Resistance in HCC and Its Combined Intervention Strategy.
Journal: Frontiers in bioscience (Landmark edition)
Published: July 31, 2025
Integrative Analysis of eQTL Genes Reveals Key Biomarkers and Mechanisms for Early Diagnosis of Pancreatic Ductal Adenocarcinoma.
Journal: Cancer informatics
Published: July 23, 2025
Research progress and frontier trends in liver cancer immunotherapy in the post-COVID-19 era (2020-2024): a visualization analysis based on bibliometric methods.
Journal: Discover oncology
Published: July 17, 2025
Serum uric acid and the risk of MASLD in Americans: A cross-sectional study combined with Mendelian randomization and network toxicology analysis.
Journal: Medicine
Published: July 08, 2025
Mendelian Randomization and Bioinformatics Analysis Reveal the Potential Protective Role of Metformin in Primary Liver Cancer.
Journal: Food science & nutrition
Published: June 22, 2025
Research trends and visualization analysis of autoimmune disease-related liver cancer from 2004 to 2024: a bibliometric study.
Journal: Discover oncology
Published: May 12, 2025
MED10 as a Novel Oncogenic Driver in HCC: Promoting Cell Cycle Progression and Proliferation Through RAF1 Activation.
Journal: Frontiers in bioscience (Landmark edition)
Published: April 24, 2025
Last Updated: 09/26/2026